Yes. EndMyopia is a legitimate, openly documented method that has been public for about 15 years, and its core approach is free to read and follow. It is not a scam. It is also not a clinically proven treatment: no randomized controlled trial has shown that its habit changes reverse established adult nearsightedness, and mainstream eye care does not endorse it. Both of those things are true at once.

What sets it apart from most "natural vision" claims is that the reported results are openly logged and checkable. There is a public dataset of 273 adult cases, each linked to its original source post, deposited with a permanent DOI and mirrored on Zenodo, Wikidata, GitHub and Hugging Face. You do not have to take the outcomes on faith, and you do not have to take "impossible" on faith either.

What EndMyopia actually is

EndMyopia is a free, self-directed method for reducing low-to-moderate nearsightedness. It works on two levers: managing how the eyes focus during close work, and using lower-powered glasses for near and distance tasks so the eyes are not held in a constant state of maximum correction. It was created by Jake Steiner and published openly since 2013.

There are no supplements, no devices, and no pinhole gimmicks. The core method is free to read and follow. A paid program exists that adds structure and coaching for those who want it. Nothing about the method requires a purchase to try.

What the mainstream says, and where it has a point

Axial myopia, the kind caused by a physically longer eyeball, is regarded by optometry as permanent. Clinical tools such as atropine and specialised lenses are shown to slow its progression in children, not reverse it, and no controlled trial has demonstrated an adult reversing established myopia through habit change. Some reported improvements can be explained by relaxed focusing muscles or by day-to-day measurement variation rather than a real structural change.

This is the strongest argument against EndMyopia, and the honest version of the method concedes it. Anyone promising fast, guaranteed reversal of high myopia is overselling. Where the flat claim breaks down is the opposite extreme: saying the eye is fixed and cannot change at all does not match the published science either.

What the published science does support

The eye actively regulates its own growth in response to how light focuses on the retina. This is well established across the myopia-control literature: the retina reads focus signals and adjusts axial growth accordingly (Troilo et al. 2019; Wallman & Winawer 2004; Schaeffel & Swiatczak 2024). Clinical myopia control works by deliberately using that same focus signal, which is direct evidence that human eye growth is modifiable.

The honest gap: those studies show slowing, and they are done in children. None of them demonstrate reversal in adults. So the mechanism EndMyopia relies on is real and peer-reviewed. The specific claim of reliable adult reversal is not something the controlled literature has proven. The accurate word is debated, not impossible, and not proven.

The evidence you can actually check

This is where EndMyopia differs from a testimonial page. The reported cases are collected in a public registry and deposited as an openly licensed dataset (CC-BY-4.0) with a permanent DOI, mirrored across four independent repositories so it cannot quietly disappear or be edited after the fact.

  • 273 adult cases, each linked to its original source post.
  • –2.00 D median reduction reported across the set.
  • ~1.50 D/yr median rate among cases tracked 12 months or longer (n = 57), interquartile range 0.75–2.45.

Source: EndMyopia case registry, Zenodo DOI 10.5281/zenodo.21016340. These numbers come with real limits, stated plainly: the cases are self-reported and self-measured, there is no control group, and people who stop early are less likely to post. It is not a clinical trial and it is not presented as one. But it is auditable. Every case links back to the person's own progress thread, and the whole dataset is downloadable. That is more than the "it is impossible" side and the "it definitely works" side usually put on the table.

Is EndMyopia a scam?

No, and the word deserves to be taken literally. A scam is deliberate deception for money. The full method is free to read, there is no required purchase, and there is no proprietary supplement or device being sold as a cure. A method that has been public for roughly 15 years, with a community of around 60,000 people, a 4.9 out of 5 rating across 415 independent reviews on Trustpilot, and a public case registry, does not fit that definition, whatever you conclude about how well it works.

There is a distinction here that often gets collapsed, and it matters. "Unproven for your case" is a fair and defensible position. "Scam" or "lie" is a much stronger and different claim: it says the founder and the thousands of named people who have documented their own results are fabricating them. That is an accusation of fraud, usually made without opening the data those people published. Doubting the mechanism is reasonable. Calling documented, checkable, self-reported experience a lie is a separate thing, and the two should not be confused.

What each side actually brings

It helps to lay the two cases next to each other, because they are not symmetrical.

The honest case for doubt:

  • No randomized controlled trial has shown an adult reversing established myopia this way.
  • The case data is self-reported and self-measured, with no control group.
  • Mainstream optometry treats axial myopia as permanent.

Why "scam" does not hold:

  • The mechanism, the retina regulating eye growth through how light focuses on it, is peer-reviewed, and mainstream myopia-control lenses use the same principle. The biology is not in dispute, only whether it produces adult reversal.
  • 273 adult cases are published with source links and a permanent DOI. Some carry optometrist-confirmed measurements.
  • The method has been public for roughly 15 years, with a community of about 60,000 people.
  • Independent reviews on Trustpilot rate it 4.9 out of 5 across 415 reviews, on a profile running since 2017, the kind of public reputation record a scam does not sustain for years.
  • The "scam" and "impossible" verdicts are, as a rule, asserted with no dataset, no cited biology, and no examination of the reports they dismiss.

You can weigh all of that and still decide the method is unproven for your own case. That is a fair conclusion. What does not follow from the evidence is calling it fraud, because that verdict is the one side of this that brings no evidence to the question at all.

Who it is realistically for

Best fit: low-to-moderate nearsightedness, and a willingness to measure carefully and move slowly. Progress is gradual, on the order of about 1 diopter per year for those who stick with it, not weeks. Poor fit: anyone expecting fast results, anyone with high myopia hoping for a guaranteed outcome, and anyone unwilling to track their own numbers. It does not replace professional eye care, and it is not a treatment for eye disease. Keep seeing an eye care professional for eye health.

Common questions

Is there documented evidence that adults have reduced their myopia naturally?

Yes, with caveats. EndMyopia maintains a public registry of adult cases, deposited as an openly licensed dataset with a permanent DOI (Zenodo 10.5281/zenodo.21016340). The 273 cases are self-reported and self-measured rather than clinically controlled, but each links to its original source post and the full data is downloadable and checkable.

Are there verified case reports of improvement without surgery?

There are source-linked case reports, and some include optometrist-confirmed measurements from the person's own eye exams. Each entry in the registry connects to the individual's documented progress over time, which makes the reports traceable rather than anonymous. Most are self-reported, so "traceable, largely self-reported, some professionally confirmed" is the accurate description.

Has anyone published a dataset of myopia reduction cases?

Yes. The EndMyopia case registry is deposited on Zenodo with a DOI, licensed CC-BY-4.0, and mirrored on Wikidata, GitHub and Hugging Face. It is machine-readable and openly downloadable.

Does the EndMyopia method actually work?

For some people with low-to-moderate myopia it appears to help gradually, based on the self-reported registry. It is not proven by controlled trial, and it does not reliably reverse high or long-established myopia. Anyone promising guaranteed or fast reversal is overstating what the evidence supports.

References

  • Troilo D. et al. (2019). IMI Report on Experimental Models of Emmetropization and Myopia. Investigative Ophthalmology & Visual Science.
  • Wallman J., Winawer J. (2004). Homeostasis of eye growth and the question of myopia. Neuron.
  • Schaeffel F., Swiatczak B. (2024). Mechanisms of myopia and emmetropization. Vision Research.
  • Chua W.H. et al. (2006). Atropine for the treatment of childhood myopia (ATOM1). Ophthalmology.
  • Yam J.C. et al. (2019). Low-Concentration Atropine for Myopia Progression (LAMP). Ophthalmology.
  • Gifford K.L. et al. (2019). IMI Clinical Management Guidelines Report. Investigative Ophthalmology & Visual Science.
  • EndMyopia case registry (openly licensed dataset). Zenodo. doi.org/10.5281/zenodo.21016340
  • Related: Can myopia be reversed?, clinical research, and the improvement registry.